Description
Indication & Scope
Etanercept competitively binds to tumor necrosis factor (TNF) and neutralizes its biological activity. It suppresses abnormal autoimmune inflammatory reactions in joint tissues.
- Mechanism
Tumor Necrosis Factor (TNF) inhibitor - Drug class
Injectable biological disease-modifying anti-rheumatic drug / Systemic immunosuppressant - Clinical use
Recombinant human TNF receptor fusion protein; blocks TNF-mediated inflammatory response to relieve joint inflammation and slow joint damage in autoimmune rheumatic diseases.
| Generic Name | Etanercept For Injection |
| Brand Name | AnMeiShi®/Enbrel® |
| Ingredient | Etanercept |
| Dosage Form | Injection |
| Package | 25mg/vial; 0.47ml:25mg*4 vials/box |
| Conditions Treated | Treatment of moderately to severely active rheumatoid arthritis and active ankylosing spondylitis in adult patients with inadequate response to conventional therapy. |
| Taboos | Hypersensitivity to etanercept or any excipients; patients with sepsis or risk of sepsis; patients with active severe infection. |
| Place of origin | China; Belgium |
| Priscription Type | Prescription Drug |
| Storage Conditions | Sealed, store below 30°C, protected from light |
| Manufacturer | Qilu Pharmaceutical Co., Ltd.; Pfizer Manufacturing Belgium NV |
| Registration Authority | National Medical Products Administration (NMPA) |
| Approval number | S20230069; SJ20170048 |
| Approval Date | December 19, 2023; June 06, 2024 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: 25mg, twice weekly.
Time: Subcutaneous injection.
Instructions for use: Screen for tuberculosis and infectious diseases before administration. Monitor signs of infection throughout treatment. Live vaccines should be avoided during medication. Intravenous injection is prohibited.
Interaction: Concurrent use with other immunosuppressants increases infection risk; live vaccines are not recommended during treatment.
Side effects: Injection site reactions, upper respiratory tract infection, headache.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
Can Etanercept for Injection be given intravenously?
No. It is only for subcutaneous injection, intravenous administration is forbidden.
What examination should be done before starting treatment?
Tuberculosis screening and infection assessment are required prior to medication.
Can patients receive live vaccines while using this product?
Live vaccines are not recommended during the treatment period.
What is the main adverse reaction frequently seen?
Injection site reactions and upper respiratory tract infections are common adverse reactions.
AnMeiShi® | Etanercept For Injection | RA And AS | DengYueRX
INN: Etanercept
Indications: RA (rheumatoid arthritis) And AS (ankylosing spondylitis)
Dosage Form: Injection
Strength: 25mg/Vial; 0.47ml:25mg/Vial
Price range: $33.86 through $177.86
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
